ScholarIQanswers from OpenAlex

Antibodies against Vascular Endothelial Growth Factor Improve Early Renal Dysfunction in Experimental Diabetes

PaperCitations, authors & open-access status

Antibodies against Vascular Endothelial Growth Factor Improve Early Renal Dysfunction in Experimental Diabetes is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Antibodies against Vascular Endothelial Growth Factor Improve Early Renal Dysfunction in Experimental Diabetes have?

ScholarIQcitation count

Antibodies against Vascular Endothelial Growth Factor Improve Early Renal Dysfunction in Experimental Diabetes has 445 citations in the OpenAlex counts ScholarIQ stores.

When was Antibodies against Vascular Endothelial Growth Factor Improve Early Renal Dysfunction in Experimental Diabetes published?

ScholarIQyear

Antibodies against Vascular Endothelial Growth Factor Improve Early Renal Dysfunction in Experimental Diabetes has 2001 year in the ScholarIQ index.

What is the open-access status of Antibodies against Vascular Endothelial Growth Factor Improve Early Renal Dysfunction in Experimental Diabetes?

ScholarIQoa status

Antibodies against Vascular Endothelial Growth Factor Improve Early Renal Dysfunction in Experimental Diabetes has closed oa status in the ScholarIQ index.

What is the DOI of Antibodies against Vascular Endothelial Growth Factor Improve Early Renal Dysfunction in Experimental Diabetes?

ScholarIQdoi

The DOI for Antibodies against Vascular Endothelial Growth Factor Improve Early Renal Dysfunction in Experimental Diabetes is on the source record.

What is the PMID of Antibodies against Vascular Endothelial Growth Factor Improve Early Renal Dysfunction in Experimental Diabetes?

ScholarIQpmid

The PMID for Antibodies against Vascular Endothelial Growth Factor Improve Early Renal Dysfunction in Experimental Diabetes is on the source record.

What is the OpenAlex record for Antibodies against Vascular Endothelial Growth Factor Improve Early Renal Dysfunction in Experimental Diabetes?

ScholarIQopenalex

The OpenAlex for Antibodies against Vascular Endothelial Growth Factor Improve Early Renal Dysfunction in Experimental Diabetes is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial